Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity

被引：12

作者：

Guan, Yangtai ^{[1
]}

Yu, Shuo ^{[1
]}

Zhao, Zhao ^{[1
]}

Ciric, Bogojub ^{[1
]}

Zhang, Guang-Xian ^{[1
]}

Rostami, Abdolmohamad ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2007年 / 192卷 / 1-2期

关键词：

APC; suppression; experimental autoimmune encephalomyelitis;

D O I：

10.1016/j.jneuroim.2007.09.021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Macrophage colony-stimulating factor (M-CSF) is a critical cytokine in the development of monocytic lineage and may have immunoregulatory properties. Here we show that peritoneal antigen presenting cells (APCs) treated with M-CSF produced decreased levels of proinflammatory cytokines IFN-gamma, TNF-alpha and IL-12. These APCs treated with M-CSF+autoantigen peptide significantly suppressed antigenspecific T cell proliferation, induced regulatory CD4(+), and CD8(+) T cells in vitro and in vivo, and significantly suppressed experimental autoimmune encephalomyelitis (EAE). Thus, in vitro treatment of APCs with M-CSF+autoantigen can be a novel therapeutic option for autoiinmune diseases. (c) 2007 Elsevier B.V All rights reserved.

引用

页码：68 / 78

页数：11

共 45 条

[1] REGULATION OF COLONY-STIMULATING FACTOR-I DURING PREGNANCY [J].

BARTOCCI, A ;

POLLARD, JW ;

STANLEY, ER .

JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (03) :956-961

[2] T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen [J].

Benson, JM ;

Campbell, KA ;

Guan, Z ;

Gienapp, IE ;

Stuckman, SS ;

Forsthuber, T ;

Whitacre, CC .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (08) :1031-1038

[3] Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis [J].

Bettelli, E ;

Pagany, M ;

Weiner, HL ;

Linington, C ;

Sobel, RA ;

Kuchroo, AK .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1073-1081

[4] Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production [J].

Brown, JA ;

Dorfman, DM ;

Ma, FR ;

Sullivan, EL ;

Munoz, O ;

Wood, CR ;

Greenfield, EA ;

Freeman, GJ .

JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1257-1266

[5] Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice [J].

Calida, DM ;

Constantinescu, C ;

Purev, E ;

Zhang, GX ;

Ventura, ES ;

Lavi, E ;

Rostami, A .

JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :723-726

[6] Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis [J].

Chen, Y ;

Langrish, CL ;

Mckenzie, B ;

Joyce-Shaikh, B ;

Stumhofer, JS ;

McClanahan, T ;

Blumenschein, W ;

Churakovsa, T ;

Low, J ;

Presta, L ;

Hunter, CA ;

Kastelein, RA ;

Cua, DJ .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1317-1326

[7] Dendritic cell-mediated T cell polarization [J].

de Jong, EC ;

Smits, HH ;

Kapsenberg, ML .

SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2005, 26 (03) :289-307

[8]

Dittel BN, 1999, J IMMUNOL, V163, P32

[9] Cutting edge:: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells [J].

Endharti, AT ;

Rifa'I, M ;

Shi, Z ;

Fukuoka, Y ;

Nakahara, Y ;

Kawamoto, Y ;

Takeda, K ;

Isobe, K ;

Suzuki, H .

JOURNAL OF IMMUNOLOGY, 2005, 175 (11) :7093-7097

[10] Cutting edge:: In vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis [J].

Faunce, DE ;

Terajewicz, A ;

Stein-Streilein, J .

JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :1991-1995

← 1 2 3 4 5 →